The authors reply

New England Journal of Medicine

Volumn 369, Issue 8, 2013, Pages 781-782

  Roncaglioni, M Carla ^a   Tombesi, Massimo ^b   Silletta, M Giuseppina ^c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CSeRMEG Centro Studi e Ricerca in Medicina Generale   (Italy)

^c Laboratorio Angela Valenti dei Fattori Genetici e Ambientali di Rischio Trombotico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO;

CARDIOVASCULAR RISK; FAT INTAKE; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERTRIGLYCERIDEMIA; LETTER; PLEIOTROPY; PRIORITY JOURNAL; RISK REDUCTION; TREATMENT OUTCOME; CARDIOVASCULAR DISEASE; FEMALE; MALE; NOTE;

CARDIOVASCULAR DISEASES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE;

EID: 84882795007     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1308780     Document Type: Letter

References (4)

1. Appendice 9.B3. Oli e grassi (g/die) (http://www.inran.it/files/download/ INRAN-SCAI/B3/appendice-9b3-oli.pdf).
2. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013;368:1279-90.
3. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-55. [Errata, Lancet 2001;357:642, 2007;369:106.]
4. Gissi-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1223-30.